This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Patrono C and Rocca B (2007) Drug insight: aspirin resistance: fact or fashion? Nat Clin Pract Cardiovasc Med 4: 42–50
Maree AO et al. (2005) Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol 46: 1258–1263
Reilly IA and FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 69: 180–186
FitzGerald GA et al. (1983) Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71: 676–688
Fontana P et al. (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost 4: 813–819
Cox D et al. (2006) Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 37: 2153–2158
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Carlo Patrono received lecture and consulting fees for AstraZeneca, Bayer AG, Eli Lilly, Nicox, Sanofi-Aventis and Servier. Bianca Rocca has received lecture fees from Nycomed.
Rights and permissions
About this article
Cite this article
Patrono, C., Rocca, B. Authors’ response to “Drug Insight: aspirin resistance—fact or fashion?”. Nat Rev Cardiol 4, E2 (2007). https://doi.org/10.1038/ncpcardio0835
Issue date:
DOI: https://doi.org/10.1038/ncpcardio0835